SCHEMBL1906121

SCHEMBL1906121

NCC(O)C(=O)N[C@@H](Cc1ccc(F)c(F)c1)C(=O)NCc1ccc(N)nc1

nearest known ligand 0.43

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
KLKB1 P03952 6/20 0.43
PDPK1 O15530 1/20 0.42
NAMPT P43490 3/20 0.40
PSMB1 P20618 1/20 0.40
PSMB5 P28074 1/20 0.40
PSMB2 P49721 1/20 0.40
FURIN P09958 1/20 0.39
MASP2 O00187 3/20 0.38
HDAC1 Q13547 1/20 0.37
MME P08473 1/20 0.35
ACE P12821 1/20 0.35
CPA1 P15085 1/20 0.35
ACE2 Q9BYF1 1/20 0.35
MET P08581 1/20 0.35
KLK1 P06870 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1907780 0.91 KLKB1 (0.45) KLKB1PDPK1NAMPTPSMB1PSMB5
SCHEMBL1905072 0.90 NAMPT (0.46) KLKB1PDPK1NAMPTPSMB1PSMB5
SCHEMBL1903988 0.90 NAMPT (0.46) KLKB1PDPK1NAMPTPSMB1PSMB5
SCHEMBL1901351 0.89 KLKB1 (0.42) KLKB1PDPK1NAMPTPSMB1PSMB5
SCHEMBL1903937 0.89 PSMB1 (0.48) KLKB1PDPK1NAMPTPSMB1PSMB5
SCHEMBL1901817 0.89 KLKB1 (0.49) KLKB1PDPK1NAMPTPSMB1PSMB5
SCHEMBL1906377 0.89 PSMB1 (0.48) KLKB1PDPK1NAMPTPSMB1PSMB5
SCHEMBL1901348 0.89 KLKB1 (0.42) KLKB1PDPK1NAMPTPSMB1PSMB5
SCHEMBL1901814 0.89 KLKB1 (0.49) KLKB1PDPK1NAMPTPSMB1PSMB5
SCHEMBL1901660 0.88 KLKB1 (0.42) KLKB1PDPK1NAMPTPSMB1PSMB5

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2011051671-A1 AMINOPYRIDINE DERIVATIVES AS KALLIKREIN INHIBITORS VANTIA LIMITED (GB) 2011-05-05 WO claimed
WO-2011051671-A1 AMINOPYRIDINE DERIVATIVES AS KALLIKREIN INHIBITORS VANTIA LIMITED (GB) 2011-05-05 WO disclosed